Woodward M, Vijverberg EGB, Di Caro V, et al. Results from COG0201: a Randomized, Placebo-controlled, Double-blind, International, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Adults with Mild-to-Moderate Alzheimer’s Disease: Focus on Pre-specified Lower p-tau217 Subgroup. Slides presented at Clinical Trials on Alzheimer’s Disease (CTAD) 2024; Madrid, Spain